Hantometer / 2026 Live 10 May 2026
May 2026 · Andes virus · person-to-person

2026 Atlantic Cruise hantavirus outbreak

In May 2026 a transatlantic cruise on the MV Hondius became the largest documented person-to-person Andes-virus event in twenty years. Genomic sequencing tied the cluster to a clade circulating in Río Negro province, suggesting a single index case who boarded already incubating.

LocationAtlantic Ocean (departed Buenos Aires, evacuated Tenerife / Cape Verde)
PeriodApril 22 — May 8, 2026
PathogenAndes virus (ANDV)
Confirmed cases6
Deaths3
Case-fatality50%
Reservoir / routePerson-to-person from a single Río Negro index passenger

Timeline

On 22 April 2026 the MV Hondius departed Buenos Aires for Tenerife with passengers from seven nationalities. By 24 April the index passenger — a 64-year-old Argentinian man from Bariloche, Río Negro — was symptomatic on board. Three crew members and two close-contact passengers developed symptoms over the following ten days. Three patients died; the others were evacuated to hospitals in Tenerife and aboard a Spanish naval medical vessel. WHO published DON 2026-DON599 on 4 May and DON 2026-DON600 on 8 May.

Why this was a person-to-person Andes-virus event

Andes virus is the only hantavirus species with documented human-to-human transmission, with prior family-cluster events totalling roughly 12% of confirmed cases. The MV Hondius cluster fits the pattern: an enclosed environment, prolonged close contact with a heavily-shedding index case, and confirmed Andes-virus genome sequencing across multiple patients matching the index strain.

Public health response

PAHO co-ordinated contact tracing across the seven nationalities represented on the manifest. Spain, Cape Verde, the United Kingdom and Argentina activated their IHR focal points. No tertiary cases (contacts of contacts) were identified, suggesting the chain ended on the ship.

Significance

The event ended the post-2005 lull in major Andes-virus person-to-person events and prompted European public-health agencies to add hantavirus to their imported-disease surveillance protocols. It also accelerated CEPI funding for Andes-virus mRNA vaccine development.